5-HT2A receptor ligands
US7094777B2 · kind B2 · utility
2Cited by
6References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 9, 2004 |
| Grant date | Aug 22, 2006 |
| Priority date | — |
| Expiry date | Nov 9, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D495/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds of formula I:are antagonists of the human 5-HT2A receptor, and hence useful in treatment or prevention of a variety of neurological conditions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.